Projects per year
Personal profile
Biography
Michael holds a PhD in virology and has studied viruses and the innate immune response to virus infections in leading laboratories around the world, e.g. at the Universities of Freiburg and Heidelberg (Germany), the Pasteur Institute in Paris (France), the Scripps Research Institute in La Jolla/San Diego (U.S.A), at the Australian National University and Australia's CSIRO. He is interested in interferon-induced proteins, animal models for viral diseases and the replication of RNA viruses (e.g. flavi- and caliciviruses). At the University of Canberra, he teaches immunology and microbiology and chairs the Committee for Ethics in Animal Experimentation. In his spare time, Michael conducts paleontological research.
Research Interests:
- Molecular virology and innate immunity
- Hepatitis viruses (HBV, HCV and HDV; rabbit caliciviruses)
- Vaccine development and gene delivery
- Paleontology
Education/Academic qualification
PhD, University of Freiburg
1992 → 1996
External positions
Visiting Scientist, CSIRO Health and Biosecurity Canberra
2014 → …Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
Hepacivirus
Medicine & Life Sciences
Thogotovirus
Medicine & Life Sciences
Virus Replication
Medicine & Life Sciences
Antiviral Agents
Medicine & Life Sciences
Rabbit Haemorrhagic Disease Virus
Medicine & Life Sciences
Interferons
Medicine & Life Sciences
Viruses
Medicine & Life Sciences
Virus Diseases
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2006 2017
IAE CRC Scholarship, Nadezda Urakova - RHD-Accelerator Platform Technology - 3.L.3 - Project 1 under 2012000263
FRESE, M. & Strive, T.
1/02/13 → 31/01/17
Project: Other
RHD-Accelerator Platform Technology - 3.L.3. Project 7 under 2012000355
1/07/12 → 30/06/17
Project: Other
Development of a hepatitis D virus-based therapeutic vaccine to treat chronic hepatitis B
1/07/12 → 31/12/14
Project: Other
Research Output 1992 2018
Restricted Host Specificity of Rabbit Hemorrhagic Disease Virus Is Supported by Challenge Experiments in Immune-compromised Mice (Mus musculus)
Urakova, N., Hall, R., Strive, T. & Frese, M., 30 Aug 2018, In : Journal of Wildlife Diseases. 55, 1, 5 p.Research output: Contribution to journal › Article
Rabbit hemorrhagic disease virus
host specificity
Mus musculus
virus
mice
A forewing of the Jurassic dragonfly Austroprotolindenia jurassica Beattie & Nel (Odonata Anisoptera) from the Talbragar Fish Bed, New South Wales, Australia
Nel, A., Frese, M., McLean, G. & Beattie, R., 2017, In : Alcheringa. 41, 4, p. 532-535 4 p.Research output: Contribution to journal › Article
dragonfly
Anisoptera (Odonata)
Odonata
New South Wales
Jurassic
1
Citations
(Scopus)
A Motif in the F Homomorph of Rabbit Haemorrhagic Disease Virus Polymerase Is Important for the Subcellular Localisation of the Protein and Its Ability to Induce Redistribution of Golgi Membranes
Urakova, N., Warden, A. C., White, P. A., Strive, T. & Frese, M., 1 Aug 2017, In : Viruses. 9, 8, p. 1-17 17 p., 202.Research output: Contribution to journal › Article
Open Access
File
Rabbit Haemorrhagic Disease Virus
RNA Replicase
Membranes
Proteins
Intracellular Membranes
3
Citations
(Scopus)
An in vivo system for directed experimental evolution of rabbit haemorrhagic disease virus
Hall, R., Capucci, L., Matthaei, K., Esposito, S., FRESE, M. & Strive, T., 2017, In : PLoS One. 12, 3, p. 1-15 15 p.Research output: Contribution to journal › Article
Open Access
File
Rabbit Haemorrhagic Disease Virus
Rabbit hemorrhagic disease virus
Viruses
Rabbits
viruses
5
Citations
(Scopus)
Broad-spectrum non-nucleoside inhibitors for caliciviruses
Netzler, N. E., Enosi Tuipulotu, D., Eltahla, A. A., Lun, J. H., Ferla, S., Brancale, A., Urakova, N., Frese, M., Strive, T., Mackenzie, J. M. & White, P. A., Oct 2017, In : Antiviral Research. 146, p. 65-75 11 p.Research output: Contribution to journal › Article
RNA Replicase
Caliciviridae
Antiviral Agents
Hepacivirus
Inhibitory Concentration 50